Six-month data comparing the Nexxt Matrixx 3D-printed titanium interbody family to PEEK devices was our top story in August. The news that Sheeraz Qureshi has joined the Hospital for Special Surgery (HSS; New York, USA) as co-chief of HSS Spine, as well as research on the association between the type of index operation and incidence of revision surgery in those with degenerative lumbar spinal stenosis, rounded out the top three. Also in our list of 10 for the month was company news from Spinal Elements, NuVasive, Kleiner Device Labs, Spineology, Abbott and Theragen.
Nexxt Spine has announced the completion of enrolment and six-month clinical data collection comparing the Nexxt Matrixx 3D-printed titanium interbody family to polyetheretherketone (PEEK) devices.
Hospital for Special Surgery (HSS; New York, USA) has announced the appointment of Sheeraz Qureshi, as co-chief of HSS Spine, effective 1 October 2022.
There is no significant association between the type of index operation—decompression alone or decompression with fusion—and incidence of revision surgery or the outcomes of pain, disability, and quality of life among patients after three years in those with degenerative lumbar spinal stenosis (DLSS). This is according to recent research, published in the JAMA Network Open by Nils H. Ulrich (University Spine Centre Zurich, Zurich, Switzerland) et al.
Spinal Elements has revealed that orthopaedic surgeon Pierce Nunley (Specialists Hospital Shreveport, Shreveport, USA), completed the first two commercial cases with its Karma minimally invasive (MIS) system.
NuVasive recently announced the resignation of its executive vice president and chief commercial officer, Massimo Calafiore. Calafiore will be leave NuVasive on August 31 to become the chief executive of a privately-held orthopaedics technology company.
Kleiner Device Labs has announced that its new KG2 Surge flow-thru interbody system was used in its first surgical procedure. Anders Cohen performed a single-level transforaminal lumbar interbody fusion (TLIF), fusing L5-S1 at The Brooklyn Hospital Center (New York, USA) on 19 July 2022.
Spineology has announced the limited launch of OptiLIF Endo—an ultra-minimally invasive system that requires just one tubular retractor to integrate endoscopes and endoscopic equipment into lumbar interbody fusion procedures.
Abbott has announced that the US Food and Drug Administration (FDA) has approved its new Proclaim Plus spinal cord stimulation (SCS) system featuring FlexBurst360 therapy.
Spatial distribution patterns of fat infiltration (FI) in the paraspinal muscles (PSMs) is a potential diagnostic biomarker that may also provide granular mechanistic insights into spine biomechanics related to chronic low back pain (cLBP), as well as advancing the use of prior summary measures limited to overall muscle FI. These are the key findings of a recent study, published in the European Spine Journal by Jeannie Bailey (University of California, San Francisco, USA) et al.
Theragen has announced that it has been granted a US patent for the development of its ActaStim-S spine fusion bone growth stimulator system.